FDA Clearance Tracker · P930016-S057
STAR S4 IR Excimer Laser System and iDESIGN Refractive Studio
Last checked: Nov 20, 2026Latest source record: Sep 9, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Sep 9, 2019
Approved
Time to decision
250 days
Received Jan 2, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P930016-S057
- Device name
- STAR S4 IR Excimer Laser System and iDESIGN Refractive Studio
- Applicant
- Amo Manufacturing USA, LLC
- Applicant location
- Milpitas, CA
- Received
- Jan 2, 2019
- Decided
- Sep 9, 2019
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P930016
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the STAR S4 IR® Excimer Laser System and iDESIGN® Refractive Studio. This device is indicated for wavefront-guided photorefractive keratectomy (PRK) in patients:1) with myopia, with or without astigmatism, as measured by iDESIGN® Refractive Studio System with spherical equivalent up to -8.00 D, and cylinder up to -3.00 D. 2) with agreement between manifest refraction (adjusted for optical infinity) and iDESIGN® Refractive Studio System refraction as follows: a) Spherical Equivalent: Magnitude of the difference is less than 0.625 D. b) Cylinder: Magnitude of the difference is less than or equal to 0.5 D. 3) in patients 18 years of age or older.4) with refractive stability (a change of </= 1.0 D in manifest refraction spherical equivalent for a minimum of 12 months prior to surgery), and5) with wavefront capture diameter of at least 4 mm.
Source documents
Other decisions for Amo Manufacturing USA, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223838 · Decided Apr 12, 2023 · 111 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.